Assessement of Microcirculation With NIRS Predicts Sepsis Development in Patients With Severe Covid-19 Pneumonia - Trial NCT06360770
Access comprehensive clinical trial information for NCT06360770 through Pure Global AI's free database. This phase not specified trial is sponsored by General and Teaching Hospital Celje and is currently Completed. The study focuses on Sepsis. Target enrollment is 35 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
General and Teaching Hospital Celje
Timeline & Enrollment
N/A
Dec 01, 2021
Apr 30, 2023
Primary Outcome
sepsis development
Summary
Sepsis and septic shock are among main causes of death in patients with severe Covid-19
 pneumonia. A few factors are proven to predict sepsis in these patients. WIth near infrared
 spectroscopy it is possible to detect microcirculatory changes typical for sepsis early in
 the course of disease. The hypothesis that changes in tissue oxygene saturation during
 vasoocclusive test predict sepsis as well as mortality in mechancally ventilated patients
 withe severe Covid-19 pneumonia will be tested.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06360770
Non-Device Trial